Our client had concerns as to whether the clinical end-points in their phase III trial were relevant...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreNew process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read moreNICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce...
Read moreOur client was seeking NICE approval for their ultra-orphan drug in an indication that was not well ...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreA cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...
Read moreOur research is aimed at identifying trends in terminated appraisals in relation to therapeutic area...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more